Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder.

McDougle CJ, Goodman WK, Leckman JF, Holzer JC, Barr LC, McCance-Katz E, Heninger GR, Price LH.

Am J Psychiatry. 1993 Apr;150(4):647-9.

PMID:
8465885
2.

Fluvoxamine treatment of obsessive-compulsive disorder.

Perse TL, Greist JH, Jefferson JW, Rosenfeld R, Dar R.

Am J Psychiatry. 1987 Dec;144(12):1543-8.

PMID:
3120604
3.

Double-blind study of adjuvant buspirone for fluoxetine-treated patients with obsessive-compulsive disorder.

Grady TA, Pigott TA, L'Heureux F, Hill JL, Bernstein SE, Murphy DL.

Am J Psychiatry. 1993 May;150(5):819-21.

PMID:
8480832
4.

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics.

McDougle CJ, Goodman WK, Leckman JF, Lee NC, Heninger GR, Price LH.

Arch Gen Psychiatry. 1994 Apr;51(4):302-8.

PMID:
8161290
5.

Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.

Goodman WK, Price LH, Delgado PL, Palumbo J, Krystal JH, Nagy LM, Rasmussen SA, Heninger GR, Charney DS.

Arch Gen Psychiatry. 1990 Jun;47(6):577-85.

PMID:
2112374
6.

Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.

Erzegovesi S, Guglielmo E, Siliprandi F, Bellodi L.

Eur Neuropsychopharmacol. 2005 Jan;15(1):69-74.

PMID:
15572275
7.

Efficacy of fluvoxamine in obsessive-compulsive disorder. A double-blind comparison with placebo.

Goodman WK, Price LH, Rasmussen SA, Delgado PL, Heninger GR, Charney DS.

Arch Gen Psychiatry. 1989 Jan;46(1):36-44.

PMID:
2491940
8.

Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.

Barr LC, Goodman WK, Anand A, McDougle CJ, Price LH.

Am J Psychiatry. 1997 Sep;154(9):1293-5.

PMID:
9286191
9.

The efficacy of fluvoxamine in obsessive-compulsive disorder: effects of comorbid chronic tic disorder.

McDougle CJ, Goodman WK, Leckman JF, Barr LC, Heninger GR, Price LH.

J Clin Psychopharmacol. 1993 Oct;13(5):354-8.

PMID:
8227493
10.

A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.

Jenike MA, Hyman S, Baer L, Holland A, Minichiello WE, Buttolph L, Summergrad P, Seymour R, Ricciardi J.

Am J Psychiatry. 1990 Sep;147(9):1209-15.

PMID:
2143637
11.

A double-blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder.

Milanfranchi A, Ravagli S, Lensi P, Marazziti D, Cassano GB.

Int Clin Psychopharmacol. 1997 May;12(3):131-6.

PMID:
9248868
12.

A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder.

Pigott TA, L'Heureux F, Hill JL, Bihari K, Bernstein SE, Murphy DL.

J Clin Psychopharmacol. 1992 Feb;12(1):11-8.

PMID:
1552034
13.

A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy.

McDougle CJ, Price LH, Goodman WK, Charney DS, Heninger GR.

J Clin Psychopharmacol. 1991 Jun;11(3):175-84.

PMID:
1820757
14.

Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.

Pato MT, Pigott TA, Hill JL, Grover GN, Bernstein S, Murphy DL.

Am J Psychiatry. 1991 Jan;148(1):127-9.

PMID:
1984696
15.

Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study.

Zohar J, Kaplan Z, Benjamin J.

J Clin Psychiatry. 1994 Mar;55(3):86-8.

PMID:
8071253
16.

The Yale-Brown Obsessive Compulsive Scale. II. Validity.

Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS.

Arch Gen Psychiatry. 1989 Nov;46(11):1012-6.

PMID:
2510699
17.

Effect of adjuvant pindolol on the antiobsessional response to fluvoxamine: a double-blind, placebo-controlled study.

Mundo E, Guglielmo E, Bellodi L.

Int Clin Psychopharmacol. 1998 Sep;13(5):219-24.

PMID:
9817627
18.

Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.

Piccinelli M, Pini S, Bellantuono C, Wilkinson G.

Br J Psychiatry. 1995 Apr;166(4):424-43.

PMID:
7795913
19.

Serotonin syndrome from fluvoxamine and buspirone.

Baetz M, Malcolm D.

Can J Psychiatry. 1995 Sep;40(7):428-9. No abstract available.

PMID:
8548727
20.

Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison.

Freeman CP, Trimble MR, Deakin JF, Stokes TM, Ashford JJ.

J Clin Psychiatry. 1994 Jul;55(7):301-5.

PMID:
8071291

Supplemental Content

Support Center